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Abstract
Background/Aims: Hyperphosphatemia is a serious complication of late-stage chronic 
kidney disease (CKD). Intestinal inorganic phosphate (Pi) handling plays an important 
role in Pi homeostasis in CKD. We investigated whether intestinal alkaline phosphatase 3 
(Akp3), the enzyme that hydrolyzes dietary Pi compounds, is a target for the treatment of 
hyperphosphatemia in CKD. Methods: We investigated Pi homeostasis in Akp3 knockout mice 
(Akp3-/-). We also studied the progression of renal failure in an Akp3-/- mouse adenine treated 
renal failure model. Plasma, fecal, and urinary Pi and Ca concentration were measured with 
commercially available kit, and plasma fibroblast growth factor 23, parathyroid hormone, and 
1,25(OH)2D3 concentration were measured with ELISA. Brush border membrane vesicles were 
prepared from mouse intestine using the Ca2+ precipitation method and used for Pi transport 
activity and alkaline phosphatase activity. In vivo intestinal Pi absorption was measured with 
oral 32P administration. Results: Akp3-/- mice exhibited reduced intestinal type II sodium-
dependent Pi transporter (Npt2b) protein levels and Na-dependent Pi co-transport activity. In 
addition, plasma active vitamin D levels were significantly increased in Akp3-/- mice compared 
with wild-type animals. In the adenine-induced renal failure model, Akp3 gene deletion 
suppressed hyperphosphatemia. Conclusion: The present findings indicate that intestinal 
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Akp3 deletion affects Na+-dependent Pi transport in the small intestine. In the adenine-
induced renal failure model, Akp3 is predicted to be a factor contributing to suppression of 
the plasma Pi concentration.
IntroductionAn elevated serum inorganic phosphate (Pi) level is an independent risk factor for mortality, and treatment with Pi binders is independently associated with improved survival in chronic kidney disease (CKD) patients [1, 2]. Findings from experimental studies support 
the epidemiologic findings: clinical practice guidelines recommend specific targets for serum Pi levels in dialysis patients [3-5]. As prevention and correction of hyperphosphatemia is a major goal of the treatment of CKD – mineral and bone disorder, special attention must be focused on Pi balance.Pi balance is maintained by intestinal absorption, renal excretion, and bone accretion. At least two types of sodium-dependent Pi co-transporters, solute carrier (SLC)34 and SLC20, are expressed in the kidney and intestine. In CKD, Pi absorption in the small intestine has an important role in Pi homeostasis. SLC34A2/Npt2b mediates intestinal transcellular Pi transport at the apical side of epithelial cells [6, 7]. Several research groups, including ours, have studied the regulation of intestinal Npt2b by vitamin D, nicotinamide (NAM), and dietary Pi [8, 9]. In addition, we developed an Npt2b inhibitor that blocks intestinal Pi transport and renal Pi excretion [10]. Recent studies demonstrated that Npt2b-null mice exhibit suppressed Na+-dependent Pi transport in the apical membrane of intestinal epithelial cells and decreased renal Pi excretion [11-13]. In a renal failure model of adenine administration 
in Npt2b knockout (KO) mice, the serum Pi concentration is significantly suppressed [11, 12, 14]. These studies indicate that Npt2b is an important target for the treatment of CKD-associated hyperphosphatemia.The main segment of the small intestine for Pi absorption in humans and rats differs from that in mice [15-18]. The ileum in mice has the highest transcellular Pi transport activity, while the jejunum in humans and rats has the highest Pi transport activity [15-20]. In rats, multiple transport systems are involved in intestinal Pi absorption [21].In humans, rats, and mice, intestinal alkaline phosphatase (IAP) is expressed throughout the gastrointestinal tract with the highest expression in the duodenum and much lower expression in the jejunum, ileum, and colon [22]. IAP is a brush border phosphomonoesterase 
that catalyzes the hydrolysis of nonspecific Pi ester bonds at an alkaline pH, and a plasma membrane-bound glycoprotein that dephosphorylates several substrates [23-26], including 
Pi additives. The mouse gut expresses three IAP isozymes: Akp3, which is expressed 
specifically in the duodenum after weaning; Akp5, which is expressed at very low levels 
throughout the gut; and Akp6, which is expressed at high levels throughout the gut [27]. Akp3 KO (Akp3-/-) mice have no overt intestinal phenotype. Akp3-/- mice fed a high fat diet become obese, and develop hyperlipidemia and hepatic steatosis [25, 28]. These changes are accompanied by an upregulation of Akp6 and FAT/CD36, a fatty acid transporter, suggesting that Akp3 negatively regulates fat absorption [24, 29]. Thus, IAP activity helps regulate intestinal lipid absorption and surfactant-like protein secretion, in addition to hydrolyzing ingested organic Pi.Several studies demonstrated that extracellular purines, notably ATP, serve as endogenous substrates for IAP [30-32]. To access the IAP catalytic site, ATP is presumably released from the enterocytes into the luminal space. Malo et al. showed that Akp3-/- mice have high luminal ATP concentrations, which affects bacterial growth in the gut [33]. Changes in the extracellular ATP concentration affect Pi transport [34-36]. In addition, extracellular ATP is expected to suppress Pi transporters [35]. Therefore, we hypothesize that increased luminal ATP levels inhibit intestinal Pi absorption in Akp3-/- mice.
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The relationship between IAP and Pi metabolism is not clear. IAP hydrolyzes Pi compounds, however, and it is thus expected that IAP is associated with dietary Pi digestion and absorption, especially in people consuming a Western diet, which generally contains many Pi additives. Using isolated renal brush border membrane vesicles (BBMVs), Storelli and Murer compared sodium-dependent transport of Pi and alkaline phosphatase activity. They showed no correlation between alkaline phosphatase activity and rate of Pi transport [37]. Furthermore, Shirazi et al., investigating the link between Pi transport and alkaline phosphatase in brush border membranes from rat small intestine, demonstrated that alkaline phosphatase inhibition does not affect the Pi transport system [38]. Kempson et al. showed that dietary Pi levels affect intestinal alkaline phosphatase activity and may be involved in Pi absorption [39]. Thus, the role of intestinal alkaline phosphatase in Pi absorption remains unclear.
Here we performed three experiments to evaluate the following: 1) the relationship between IAP and Pi transport (Npt2b levels), 2) the phenotype of Akp3-/-, and 3) the effect 
of Akp3 on Pi metabolism in animals with adenine-induced renal insufficiency. Our findings indicated that Akp3 is an important regulator of Npt2b and intestinal Pi transport in mice.
Materials and Methods
Animals and DietMice were maintained under pathogen-free conditions and handled in accordance with the Guidelines for Animal Experimentation of Tokushima University School of Medicine. For wild-type mice, male C57BL/6J mice were purchased from Charles River Laboratories Japan (Yokohama, Japan). Akp3-/- mice were generated as described previously [25].  Crossing male and female Akp3+/− mice yielded Akp3+/+ and Akp3−/− mice. Genomic DNA was extracted from tail clippings and amplified by polymerase chain reaction 
(PCR) using specific primers, as described previously (Table 1) [25]. Mice were weaned at 4 weeks of age, 
and provided free access to water and standard mouse chow (1.06% Ca and 0.99% Pi; CLEA Japan, Inc., Tokyo, Japan).
For the dietary adaptation study, mice were fed a test diet (low Pi; 0.02% Pi, control Pi; 0.6% Pi, and 
high Pi; 1.2% Pi) for 7 days. KH2PO4 was used for this dietary adaptation.Adenine-induced nephritis was produced in mice by oral gavage of adenine dissolved in vehicle (carboxymethyl cellulose) [12]. Eleven-week-old male mice were administered adenine (50-100 mg/kg body weight) 3 times per week. Control mice were orally administered an equivalent volume of vehicle. The experimental schedule was described previously [12].
Metabolic cages to collect urine and feces samplesMice were individually caged to collect 24-h urine and feces samples. Fecal samples were ashed using 
a modified protocol [40]. The fecal samples were collected and placed into beakers to dry at 110°C for up to 
24 h. The samples were then ashed at 250°C for 3 h and 550°C for 24 h in a muffle furnace. The samples were 
cooled, weighed, and digested in HCl with heat, and the sample volume was standardized to 5 ml.
Pi, Ca, Cre, FGF23, and PTH concentrationsConcentrations of plasma or urinary inorganic Pi, calcium (Ca), and creatinine (Cre) were determined using commercial kits (Wako, Osaka, Japan). 
Concentrations of plasma intact fibroblast growth factor 23 (FGF23) proteins and parathyroid 
hormone (PTH) were determined using the FGF-23 ELISA kit (KAINOS Laboratories, Tokyo, Japan) 
and intact PTH ELISA kit (Immunotopics Inc., San Clemente, CA), respectively. Metabolic cages were used to collect the 24-h urine samples.
Table 1. Primers for genotyping  Primer name Sequences Akp3 (WT allele) Sense AGTTCAGTTCCCACATACCTGG Antisense CCAAACATACTGGGATCCCTAG Akp3 (Targeted allele) Sense TGTGCTCGACGTTGTCACTGAA Antisense CGATACCGTAAAGCACGAGG                            
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RNA extraction and cDNA synthesisTotal RNA was extracted from mouse tissues using ISOGEN (Wako, Osaka Japan) according to the manufacturer’s instructions. After treatment with DNase I (Invitrogen, Carlsbad, CA), cDNA was synthesized using the Moloney murine leukemia virus, reverse transcriptase (Invitrogen), and oligo(dT)12-18 primer.
Quantitative PCRQuantitative PCR was performed using ABI PRISM 7500 (Applied Biosystems, Foster City, CA). The reaction mixture comprised 10 ml of SYBR Premix Ex Taq, ROX Reference Dye II (Perfect Real Time, Takara, 
Osaka, Japan), and specific primers. The PCR reactions were initiated with denaturation at 95°C for 10s, and 
annealing at 60°C for 15s and at 72°C for 15s. Data were evaluated with SDS v. 1.2X with RQ software. The PCR primer sequences are shown in Table 2.
Protein sample purificationBBMVs were prepared from mouse intestine and kidneys using the Ca2+ precipitation method, as described previously. Protein concentrations were measured using the BCA protein assay kit (Pierce, Rockford, IL).
AntibodiesPolyclonal rabbit anti-Npt2a and Npt2c antibodies were generated as described previously [41]. Polyclonal rabbit anti-Npt2b antibody was purchased from Alpha Diagnostic International (San Antonio, TX). Polyclonal rabbit anti-Akp3, Akp5, and Akp6 antiserum were used as described previously [24].
ImmunoblottingProtein samples were denatured with 2-mercaptoethanol and subjected to 8% or 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The separated proteins were transferred by electrophoresis 
to Immobilon-P polyvinylidene difluoride (Millipore, Billerica, MA) and then treated with the following 
diluted antibodies: affinity-purified anti-Npt2a (1:2000), Npt2b (1:1000) antibodies, and Npt2c (1:3000), 
Akp3 (1:8000), Akp5 (1:10, 000), and Akp6 (1:100, 000) antiserum. Mouse anti-actin monoclonal antibody 
(Chemicon, Temecula, CA) was used as an internal control. Horseradish peroxidase-conjugated anti-rabbit or anti-mouse IgG was utilized as the secondary antibody (Jackson Immuno Research Laboratories, Inc., West Grove, PA), and signals were detected using Immobilon Western (Millipore).
Measurement of intestinal alkaline phosphatase activityProximal and distal BBMVs were used for alkaline phosphatase measurement. The proximal intestine refers to the duodenum and the proximal part of the jejunum. The distal intestine refers to the late jejunum and ileum. Intestinal BBMVs (20 µg) were mixed with phosphatase assay reagent including 4 mM disodium-
p-nitrophenyl Pi and 0.1 M glycine (pH 9.0), 1 mM MgCl2, and incubated at 37°C for 20 min. The reaction 
was stopped by adding 0.05 mM NaOH to the reaction mixture. A calibration curve was prepared with p-nitrophenol and absorbance was measured at 400 nm. Alkaline phosphatase activity per microgram protein was calculated.
Measurement of intestinal ATPThe gastrointestinal contents were washed out from the proximal and distal intestine with distilled water and vortexed vigorously. Samples were centrifuged at 3000xg for 10 min and an aliquot of the supernatant was used to determine the ATP concentration using a commercial ATP assay kit (Toyo Ink) according to the manufacturer’s instructions.
Table 2. Primers for real-time PCR.  1) = 
1a-Hydroxylase, 2) = 24-Hydroxylase, 3) = glyceraldehyde-3-phosphate dehydrogenase
 2 
  Primer name Sequences 
1aOHase1) Sense GAGCAAACTCCAGGAAGCAG Antisense TGAGGAATGATCAGGAGAGG 
24OHase2) Sense TGGGAAGATGATGGTGACCC Antisense TCGATGCAGGGCTTGACTG 
GAPDH3) Sense CTGCACCACCAACTGCTTAGC Antisense CATCCACAGTCTTCTGGGTG 
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Measurement of Pi transport activityBBMV Pi transport activity was measured in the mouse small intestine and kidney using a rapid 
filtration technique, as described previously [12].Intestinal absorption was assessed based on the 32P blood level (cpm) after gavage of a test solution 
using a previously described protocol with modifications [10, 42]. The test solution (pH7.4) contained 128 mM NaCl, 4.7 mM KCl, 2.5 mM CaCl2, 1.2 mM MgSO4, and 4 mM KH2PO4 (80 µCi/ml). For the study, 15 µl of the test solution per gram body weight was administered by gavage. Blood samples were obtained at the indicated time-points and analyzed by liquid scintillation counting.
Cell cultureThe rat cell line IEC-6 (ATCC, Manassas, VA) was maintained in DMEM (Sigma-Aldrich, St. Louis, MO) supplemented with 10% FBS, as described previously [43, 44]. BzATP triethylammonium salt, an activator of the P2X receptors, was obtained from Wako (Tokyo, Japan). Monoclonal rabbit anti-P2X7 receptor antibody was purchased from Cell Signaling (Danvers, MA).
Statistical analysisData are expressed as means ± standard error of the mean. The significance of differences between two experimental groups was established by ANOVA followed by Student’s t test. Differences among multiple groups were analyzed by ANOVA followed by Scheffe’s test. A P value of less than 0.05 was considered 
significant.
Results
In the first set of experiments, we analyzed the effect of the dietary Pi content on IAP activity and Akp3 protein levels in the proximal and distal intestine. Plasma Ca concentrations 
were significantly higher in mice fed the LP diet than in mice fed the CP diet (Fig. 1A). Urinary 
Ca excretion levels were significantly higher in mice fed the LP diet than in the other groups 
(Fig. 1B). In contrast, plasma Pi and urinary Pi excretion levels were significantly lower in mice fed the LP diet than in the other groups (Fig. 1C and 1D). As described previously, IAP activity levels were markedly higher in the proximal intestine than in the distal intestine (Fig. 1E and 1F). Furthermore, IAP activity was higher in the proximal intestine, but not in the distal intestine, of mice fed the LP diet than in mice fed the high Pi diet (Fig. 1E and 1F). Akp3 mRNA is exclusively expressed in the duodenum [24]. We examined Akp3 protein 
expression in the proximal intestine of mice fed the LP, CP, or HP diets (Fig. 1G). Akp3 protein 
expression was significantly higher in the proximal intestine of mice fed the LP diet than in 
mice fed the CP and HP diets (Fig. 1G). Npt2b protein expression was significantly higher 
in the distal intestine of mice fed the LP diet than in mice fed the HP diet (Fig. 1H). These 
findings indicate that IAP/Akp3 is regulated by the dietary Pi content, as reported previously [39].
Next, we examined how such IAP fluctuations affect systemic Pi metabolism using Akp3-/- mice. Kaliannan et al. reported that Akp3-/- mice fed normal mouse chow exhibit metabolic endotoxemia and metabolic syndrome [45]. First, we examined whether Akp3-/- mice fed normal chow exhibit inflammation or lipid metabolism abnormalities. 
We confirmed the loss of Akp3 mRNA and protein expression in the proximal intestine of Akp3-/- mice (Fig. 2A and 2B). Alkaline phosphatase activity in the proximal intestine, but not the distal intestine, of Akp3-/- mice was significantly decreased (Fig. 2C). In the present study, we examined Akp3-/- physiology to confirm the previous findings (Fig. 2D-G). Body weight gain and the levels of lipid parameters, including total cholesterol, triglyceride, and 
endotoxin, which is an inflammation marker, were not altered in Akp3-/- mice compared with Akp3+/+ mice (Fig. 2D-2G). An intestinal permeability study using fluorescein isothiocyanate-
dextran revealed no significant differences between Akp3+/+ and Akp3-/- mice (Fig. 2H). In a previous study, Akp3-/- mice exhibited increased levels of inflammation markers [45]. 
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In the present study, Akp3-/- animals ingesting the normal chow did not exhibit the 
evaluated inflammation markers (data not 
shown). These findings imply some genetic drift in the genome of the Akp3-/- mice depending on the colony, and/or unknown effect(s) resulting from slight differences between the control diets.
To confirm whether Akp3-/- mice have abnormal changes in Ca and Pi metabolism, we measured biologic data, intestinal and renal Pi transport activity, and transporter expression in Akp3-/- mice. Food intake did not differ between Akp3+/+ and Akp3-/- mice at 9 weeks of age (Fig. 3A). Urinary volume and plasma Cre levels did 
not differ significantly between Akp3+/+ and Akp3-/- mice (Fig. 3B and 3C). Furthermore, blood, urinary, and fecal excretion levels of Ca and Pi did not differ 
significantly between Akp3+/+ and Akp3-/- mice (Fig. 3D-3I).Although plasma 
FGF23 and PTH levels did not differ between Akp3+/+ and Akp3-/- mice, 
1,25(OH)2D3 levels 
were significantly increased in Akp3-/- mice compared with Akp3+/+ mice (Fig. 3J-3L). The 
renal 1α-hydroxylase mRNA levels were not different between      Akp3-/- mice and Akp3+/+ 
mice, whereas the renal 24-hydroxylase mRNA levels were significantly decreased in Akp3-/- mice compared with Akp3+/+ mice (Fig. 3M and 3N).
Fig. 1. Dietary Pi regulation of intestinal alkaline and phosphatase Pi transporter. (A-D) Metabolic cages were used for 24-h urine collection from male C57BL6 mice 9-10 weeks of age fed the low Pi (LP), control Pi (CP), 
or high Pi (HP) diet for 7 days (n=5-6/group). BBMVs were isolated from 
intestines of mice fed the LP, CP, or HP diet. (E and F) The intestines were divided into proximal and distal segments to measure alkaline phosphatase activity. Values are mean ± SE. *p＜0.05. (G and H) Western blotting analysis of Akp3 in the proximal intestine and intestinal sodium-dependent transporter Npt2b in the distal intestine. Actin was used as the internal control. Relative intensity values for CP were mean ±SE. *p＜0.05, **p<0.01.
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Renal Pi transport activity and renal sodium-dependent transporter protein levels were 
not significantly different between Akp3-/- mice and Akp3+/+ mice (Fig. 4A and 4B). In contrast, 
intestinal Pi transport activity and intestinal Npt2b protein expression were significantly decreased in Akp3-/- mice compared with Akp3+/+ mice (Fig. 4C and 4D). Previous reports revealed that extracellular or intracellular ATP levels regulate Na+-dependent Pi transport activities in the proximal tubular cells [34, 46]. To determine the reason for the reduced Npt2b protein expression, we hypothesized that ATP, which is a substrate of Akp3, is involved in regulating Npt2b expression. Luminal ATP levels were higher in both the proximal and distal intestine of Akp3-/- mice compared with Akp3+/+ mice (Fig. 4E and 4F), as described 
previously [33]. The intestinal cellular ATP level did not differ significantly between Akp3+/+ mice and Akp3-/- mice (data not shown).Purine nucleotides are well established extracellular signaling molecules [47]. P2X purinoceptor 7 (P2X7) is a member of the family of ionotropic ATP-gated receptors that localizes at the apical membrane of the epithelial cells of the mouse ileum [43, 47]. To examine whether ATP suppresses Npt2b expression, we used the normal rat cell line IEC-6. We detected P2X7 protein expression in the distal intestine and kidney of normal mice (Fig. 5A) and also in the distal intestine of Akp3+/+ and Akp3-/- mice (Fig. 5B). Npt2b and P2X7 receptor were also detected in normal rat cell line IEC-6 cells (Fig. 5C). The P2X7 receptor agonist (BzATP) suppressed Npt2b protein levels in IEC-6 cells (Fig. 5D).
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Fig. 2. Akp3-/- mice fed normal chow had normal lipid metabolism. Male Akp3+/+ and Akp3-/- mice 9-10 weeks of age (n=5-6/group). (A) Akp3, Akp5, and Akp6 mRNA and (B) protein in the proximal intestine of Akp3+/+ and Akp3-/- mice. (C) Intestines of Akp3+/+ and Akp3-/- mice were divided into proximal and distal segments for measurement of alkaline phosphatase activity. (D) Body weight, (E) blood total cholesterol, 
(F) triglyceride, and (G) endotoxin concentrations. (H) An intestinal permeability study using fluorescein isothiocyanate-dextran in male Akp3+/+ and Akp3-/- mice at 9-10 weeks of age (n=5-6). Values are mean ±SE.
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Fig. 3. Biologic parameters for Ca and Pi homeostasis in Akp3+/+ and Akp3-/- mice. Metabolic cages were used for 24-h food intake, urine and feces collection from male Akp3+/+ and Akp3-/- mice 9-10 weeks of age (n=5-6/group). (A) Food intake, (B) urine volume, (C) plasma Cre, (D) ionized Ca, (E) urinary Ca excretion, (F) fecal Ca excretion, 
(G) plasma Pi, (H) urinary Pi excretion, (I) fecal Pi excretion, (J) plasma intact FGF23, (K) plasma 
intact PTH, and (L) plasma 
1 , 2 5 ( O H ) 2 D 3 . Values are mean ±SE. *p＜0.05. Real-time PCR (M) 
1 α - h y d r o x y l a s e 
(1αOHse and (N) 2 4 - h y d r o x y l a s e 
(24OHase) mRNA levels in the kidneys of male Akp3+/+ and Akp3-/- mice at 9-10 weeks of age (n=5-6/group) were assessed by real-time PCR. 
GAPDH was used as an internal control. Values are mean ±SE. *p＜0.05.
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Fig. 4. Renal and intestinal Pi transport activity and transporter expression levels in Akp3+/+ and Akp3-/- mice. BBMVs were isolated from the kidney and distal intestine of male Akp+/+ and Akp3-/- mice 9-10 weeks of age (n=5-6). (A and C) Time-course of sodium-dependent Pi transport was examined using kidney and distal intestine. Values were mean ±SE, *p＜0.05. (B and D) Western blotting analysis of renal and intestinal sodium-dependent Pi transporters. Each lane was loaded with 20 µg of BBMV. Actin was used as the internal control. Relative intensity values were mean ±SE, *p＜0.05. Luminal ATP concentration levels in the proximal (E) and distal (F) intestine of male Akp3+/+ and Akp3-/- mice 9-10 weeks of age. Data are presented as means ± SE. *p<0.05, n=4-6/group.
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Several studies report that the loss of intestinal Npt2b delays the progression of kidney disease [11, 12, 14]. As shown in Fig. 4C and 4D, Akp3-/- mice exhibited reduced intestinal BBMV Pi transport activity and Npt2b protein expression. We used an experimental mouse model having adenine-induced renal failure with hyperphosphatemia in Akp3-/- mice to observe the progression of renal failure (Fig. 6). As described in the Materials and Methods, adenine was orally administered to Akp3+/+ and Akp3-/- mice. In the Akp3+/+ adenine-treated 
group, plasma Cre and Pi concentrations were significantly increased compared with the Akp3+/+ control group and Akp3-/- control and adenine-treated groups (Fig. 6A and 6B). In the Akp3+/+ adenine-treated group, intestinal Akp3 protein expression was not changed, and 
Npt2b protein expression was significantly suppressed compared with the Akp3+/+ control 
group (Fig. 6C-6E). The Npt2b protein levels did not differ significantly between the Akp3-/- control and adenine-treated groups (Fig. 6C and 6E).Finally, we performed in vivo absorption study using oral administration of 32P in Akp3+/+ and Akp3-/- mice (Fig. 7). In intact animals, the rates of Pi absorption did not differ 
significantly between the Akp3+/+ and Akp3-/- mice (Fig. 7A). In the Akp3+/+ mice with adenine-induced renal failure, the rates of Pi absorption (32P transfer from intestine to the blood) were not altered compared with those in the vehicle-treated Akp3+/+ mice (Fig. 7B). In contrast, in Akp3-/- mice with adenine-induced renal failure, the rates of Pi absorption (32P 
transfer from intestine to the blood) were significantly decreased compared with those in the vehicle-treated Akp3-/- mice (Fig. 7B). Thus, a significant reduction in Pi absorption was observed in Akp3-/- mice with renal failure.
Fig. 5. Expression of Npt2b and P2X7 receptor. Western blotting analysis. (A) BBMVs were isolated from the proximal and distal intestine, and the kidneys of WT mice. (B) BBMVs were isolated from the distal intestine of male Akp3+/+ and Akp3-/- mice 9-10 weeks of age. (C) Western blotting analysis. Npt2b and P2X7 receptor were detected in normal rat IEC-6 cells. For the experiment, total protein was extracted 2, 4, and 6 days after 
the cells reached 100% confluence.  (D) For the experiment, total protein was extracted 6 days after 100% 
confluence. IEC-6 cells were stimulated with 100 µM BzATP. Western blotting analysis. Data are represented as means ± SE. *p<0.05 compared with the non-stimulated control.
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Fig. 6. Adenine-induced renal failure in Akp3+/+ and Akp3-/- mice. Plasma Cre (A) and plasma Pi (B) levels at the end of the study are shown. Values are means ± SE. *p<0.05, p**<0.01, (C-E) Intestinal Akp3 and Npt2b protein expression levels were assessed by Western blotting analysis. Male mice 9-10 weeks of age (n = 5-7/group) were used. Each lane was loaded with 20 µg of BBMV. Actin was used an internal control. ND, not detected. Values are means ± SE. *p<0.05.
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Fig. 7. In vivo intestinal Pi absorption in Akp3+/+ and Akp3-/- mice. (A) Intestinal phosphate absorption assays in Akp3+/+ and Akp3-/- mice. Change in the blood Pi (cpm) after administration of 32P. Values are mean ± SE, n=4-6. (B) Intestinal phosphate absorption assays in Akp3+/+ and Akp3-/- mice with adenine-induced renal failure at 10 and 60 min after administration of the test solution. Values are mean ± SE, *p＜0.05, n=4-5.
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Discussion
Our findings revealed that dietary Pi levels control intestinal Npt2b and Akp3 in a similar direction. Deletion of the Akp3 gene suppresses intestinal Npt2b protein and sodium-dependent Pi co-transport activities in isolated BBMVs. The reduced Pi absorption may stimulate an increase in the plasma active vitamin D concentration by suppressing 24-hydroxylase mRNA levels in the kidney. Furthermore, increases in the plasma Pi 
concentration were significantly suppressed in Akp3-/- mice with adenine-induced renal failure compared with Akp3+/+ mice. In the Akp3-/- mouse adenine-induced renal failure model, the rate of transfer of 32P-labeled Pi from the intestine to the blood was significantly decreased compared with that of the Akp3-/- control mice. Thus, Akp3 is predicted to be an important factor in intestinal Pi handling.
In Npt2b KO mice, the active vitamin D and fecal Pi excretion levels were significantly 
increased and FGF23, PTH, and urinary Pi excretion levels are significantly suppressed compared with wild-type mice [11]. In the present study, we demonstrated that Akp3-/- mice with reduced Npt2b levels in the small intestine had decreased BBMV sodium-dependent transport activity and increased active vitamin D levels. We observed no changes in the 
plasma Pi, PTH, and FGF23 levels and fecal and urinary Pi excretion levels, however, in Akp3-/- mice. We expect that the difference in the responsiveness of vitamin D metabolism between Npt2b KO and Akp3-/- mice depends on their different levels of suppression of sodium-dependent Pi absorption.In addition, in adenine-induced hyperphosphatemic model mice, the increase in the 
plasma Pi concentration was significantly suppressed in Akp3-/- mice. These data indicate that Pi transfer from intestinal epithelial cells to the blood may be affected by deletion of 
the Akp3 gene. Similar findings were obtained in Npt2b-deletion mice [11, 12]. In Npt2b-
deletion mice, the increase in the plasma Pi concentrations was significantly suppressed in 
an adenine-induced renal failure model [11, 12]. Taken together, these findings suggest that active Pi transport in the small intestine is decreased in Akp3-/- mice, and that suppression of Akp3 could be a novel Pi regulator in the renal failure model.
In mice, Akp3 is mainly expressed as a duodenal-specific IAP, while Npt2b is located in the ileum [17, 18, 24, 28]. Thus, the functional sites of both molecules are different. Akp3 is thought to be secreted from the duodenum, however, and to function in the intestinal lumen. In Escherichia coli and yeast, alkaline phosphatase or acid phosphatase is secreted, 
catalyzes a Pi-containing compound, and efficiently transports the released Pi from the cell membrane [48]. In the mouse small intestine, we speculate that secreted Akp3 from the duodenum and upper jejunum catalyze Pi-containing compounds and release inorganic Pi, 
which is efficiently absorbed in the ileum. It is expected that a system for digesting such Pi compounds is present in the proximal part and that the liberated inorganic Pi is absorbed in the distal part of the small intestine.In our previous study, Npt2b KO did not affect Pi absorption within the range of Pi 
concentrations that normally occurs after meals, but significantly decreased urinary Pi excretion in mice [49]. We suggested that abnormal Pi metabolism might be involved in tight junction molecules, such as claudins, that are affected by Npt2b deletion [49]. In the present study, Akp3-/- mice did not have excessive levels of Pi fecal excretion and hypophosphatemia compared with Akp3+/+ mice. Although further studies are necessary, it is possible that intestinal Pi absorption, such as by the paracellular system, compensates for the loss of intestinal Npt2b in Akp3-/- mice.Based on this study, it is not clear how deletion of Akp3 leads to the suppression of ileum Npt2b. Previous studies reported that extracellular or intracellular nucleic acids such as ATP and NAD regulate Na+-dependent Pi transport activities or/and sodium-dependent transporter expression [34, 50]. To investigate the mechanisms involved in the suppression of Npt2b protein in intestinal epithelial cells in Akp3-/- mice, we analyzed the luminal concentration of ATP. Because ATP, ADP, and nucleotides are well-known substrates of IAP, 
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the lack of Akp3 increases luminal ATP concentrations. Cellular ATP levels in the intestinal cells of Akp3-/- mice were not different from those in Akp3+/+ mice (data not shown). In a 
previous study, Malo et al. reported that luminal ATP concentrations are significantly increased in Akp3-/- mice [33]. They confirmed that local Akp3 bioactivity creates a luminal environment that promotes the growth of a wide range of organisms [33]. Therefore, it is possible that luminal ATP and other nucleotides downregulate intestinal Pi absorption. In fact, inhibition of IAP inhibits intestinal Pi transport [38].More recently, Brun et al. showed that Akp3-/- mice display higher intestinal Ca uptake and Ca retention [51]. Some previous reports indicate that high dietary Ca concentrations decrease Pi digestibility and absorption [52, 53]. Furthermore, Uekawa et al. demonstrated that luminal ATP metabolism regulates transcellular Ca transport in the intestine by an 
1,25(OH)2D3-independent mechanism in response to dietary Pi levels [54]. They reported that, in cultured intestinal epithelial cells, low Pi increased ATP in the apical side medium and allowed Ca entry into epithelial cells via the P2X7 receptor, resulting in increased Ca transport [54]. In the present study, the P2X7 receptor agonist suppressed Npt2b protein levels in IEC cells. In these contexts, in the present study, Akp3-/- mice showed high ATP concentrations in the intestinal lumen, suggesting that luminal ATP levels affect intestinal Ca and Pi transport. Further research is necessary to determine the factors and mechanisms involved in the inhibition of intestinal Npt2b and sodium-dependent transport activity in Akp3-/- mice.Finally, in the present study, Akp3-/- mice exhibited suppressed Npt2b protein expression and intestinal sodium-dependent transport. This mouse model is important for elucidating intestinal Pi absorption mediated by Npt2b. It is unclear why intestinal Npt2b protein is reduced in Akp3-/- mice, and further studies are needed to evaluate this point. Although the Akp3-/- mice exhibited suppressed renal 24-hydroxylase and intestinal Npt2b protein levels, the physiologic effect on Akp3-/- mice appeared to be less important for Pi homeostasis under normal conditions because we did not detect plasma Pi concentrations and fecal Pi levels in intact Akp3-/- mice. In the renal failure model, however, Akp3 deletion significantly suppressed Pi absorption (the transfer of Pi from the intestine to the blood). We suggest that Akp3 has more important roles in Pi absorption in the renal failure model than in normal conditions.Furthermore, it is necessary to clarify whether the importance of Akp3 for Pi homeostasis is unique to the mouse or if this is the case in rats as well (as a potential model for human intestinal Pi absorption). Intestinal Akp3 may be an important target for the treatment of CKD-associated hyperphosphatemia. A better understanding of the regulatory molecules involved in intestinal Pi handling will elucidate novel treatment targets for hyperphosphatemia other than Pi binders.
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